Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome

Journal of Child Psychology and Psychiatry and Allied Disciplines

Volumn 58, Issue 1, 2017, Pages 64-74

  Dykens, Elisabeth M ^a,b   Roof, Elizabeth ^a   Hunt Hawkins, Hailee ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

adaptive behavior; cognition; growth hormone treatment; Prader Willi syndrome

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ADULT; AGE; CHILD; COPING BEHAVIOR; DAILY LIFE ACTIVITY; DRUG EFFECTS; FEMALE; HUMAN; INTELLIGENCE; INTERPERSONAL COMMUNICATION; MALE; PRADER-WILLI SYNDROME; PRESCHOOL CHILD; TIME FACTOR; YOUNG ADULT;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COMMUNICATION; FEMALE; GROWTH HORMONE; HUMANS; INTELLIGENCE; MALE; PRADER-WILLI SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 84994451604     PISSN: 00219630     EISSN: 14697610     Source Type: Journal    
DOI: 10.1111/jcpp.12601     Document Type: Article

References (45)

1. Anderson, D.L., Campos, J.J., Witherington, D.C., Dahl, A., Rivera, M., He, M., … & Barbu-Roth, M. (2013). The role of locomotion in psychological development. Frontiers in Psychology, 4, Article 440.
2. Bakker, N.E., Siemensma, E.P., van Rijn, M., Festen, D.A., & Hokken-Koelega, A.C. (2015). Beneficial effect of growth hormone treatment on health-related quality of life in children with Prader-Willi syndrome: A randomized controlled trial and longitudinal study. Hormone Research in Paediatrics, 84, 231–239.
3. Bertella, L., Mori, I., Grugni, G., Pignatti, R., Ceriani, F., Molinari, E., … & Semenza, C. (2007). Quality of life and psychological well-being in GH-treated, adult PWS patients: A longitudinal study. Journal of Intellectual Disability Research, 51, 302–311.
4. Bodfish, J.W., Symons, F.J., Parker, D.E., & Lewis, M.H. (2000). Varieties of repetitive behavior in autism: Comparisons to mental retardation. Journal of Autism and Developmental Disorders, 30, 237–243.
5. Boer, H., Holland, A., Whittington, J., Butler, J., Webb, T., & Clarke, D. (2002). Psychotic illness in people with PWS due to chromosome 15 maternal uniparental disomy. Lancet, 359, 135.
6. Böhm, B., Ritzén, M., & Lindgren, A.C. (2015). Growth hormone treatment improves vitality and behavioural issues in children with Prader-Willi syndrome. Acta Paediatrica, 104, 59–67.
7. Camfferman, D., Lushington, K., O'Donoghue, F., & McEvoy, R.D. (2006). Obstructive sleep apnea syndrome in Prader-Willi syndrome: An unrecognized and untreated cause of cognitive and behavioral deficits? Neuropsychology Review, 16, 123–129.
8. Cassidy, S.B., Schwartz, S., Miller, J.L., & Driscoll, D.J. (2012). Prader-Willi syndrome. Genetics in Medicine, 14, 10–26.
9. Castro, J.R., Costoya, J.A., Gallego, R., Prieto, A., Arce, V.M., & Señarís, R. (2000). Expression of growth hormone receptor in the human brain. Neuroscience Letters, 281, 147–150.
10. Deal, C.L., Tony, M., Höybye, C., Allen, D.B., Tauber, M., Christiansen, J.D., & the Growth Hormone in PWS Clinical Guidelines Participants (2013). Growth hormone research society workshop summary: Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism, 98, E1072–E1087.
11. Dickens, W.T., & Flynn, J.R. (2001). Heritability estimates versus large environmental effects: The IQ paradox resolved. Psychological Review, 108, 346–369.
12. Dykens, E.M., Hodapp, R.M., Walsh, K., & Nash, L.J. (1992). Profiles, correlates and trajectories of intelligence in Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1125–1130.
13. Dykens, E.M., Lee, E., & Roof, E. (2011). Prader-Willi syndrome and autism spectrum disorders: An evolving story. Journal of Neurodevelopmental Disorders, 3, 225–237.
14. Dykens, E.M., Maxwell, M., Pantino, E., Kossler, R., & Roof, E. (2007). Assessment of hyperphagia in Prader-Willi syndrome. Obesity, 15, 1816–1826.
15. Dykens, E.M., & Roof, E. (2008). Behavior in Prader-Willi syndrome: Relationship to genetic subtypes and age. Journal of Child Psychology and Psychiatry, 49, 1001–1008.
16. Emerick, J.E., & Vogt, K.S. (2013). Endocrine manifestations and management of Prader-Willi syndrome. International Journal of Pediatric Endocrinology, 14, 1–10.
17. Falletia, M.G., Maruffa, P., Burman, P., & Harris, A. (2006). The effects of growth hormone deficiency and replacement on cognitive performance in adults: A meta-analysis of the current literature. Psychoneuroendocrinology, 31, 681–691.
18. Festen, D.A., Wevers, M., Lindgren, A.C., Böhm, B., Otten, B.J., Wit, J.M., … & Hokken-Koelega, A.C. (2008). Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clinical Endocrinology, 68, 919–925.
19. Garcia, G., Logan, G.E., & Gonzalez-Heydrich, J. (2012). Management of psychotropic medication side effects in children and adolescents. Child and Adolescent Psychiatric Clinics of North America, 21, 713–738.
20. Hennessy, S., Bilker, E.B., Berlin, J.A., & Strom, B.L. (1999). Factors influencing the optimal control-to-case ratio in matched case-control studies. American Journal of Epidemiology, 49, 195–197.
21. Höybye, C., Thoren, M., & Bohm, B. (2005). Cognitive, emotional, and physical, and social effects of growth hormone treatment in adults with Prader-Willi syndrome. Journal of Intellectual Disability Research, 49, 245–252.
22. Kaufman, J.C., & Kaufman, A.S. (2001). Time for the changing of the guard: A farewell to short forms of intelligence tests. Journal of Psychoeducational Assessment, 19, 245.
23. Kaufman, A.S., & Kaufman, N.L. (2004). Kaufman Brief Intelligence Test-2. Minneapolis, MN: Pearson.
24. Key, A.P., Jones, D., & Dykens, E.M. (2013). Social and emotional processing in Prader-Willi syndrome: Genetic subtype differences. Journal of Neurodevelopmental Disorders, 5, 7.
25. Lo, S.T., Festen, D.A.M., Tummers-de Lind van Wijngaarden, R.F.A., Collin, P.J.L., & Hokken-Koelega, A.C.S. (2015). Beneficial effects of long-term growth hormone treatment on adaptive functioning in infants with Prader-Willi syndrome. American Journal of Intellectual and Developmental Disabilities, 120, 315–327.
26. Lo, S.T., Siemensma, E.P., Festen, D.A., Collin, P.J., & Hokken-Koelega, A.C. (2015). Behavior in children with Prader-Willi syndrome before and during growth hormone treatment: A randomized controlled trial and 8-year longitudinal study. European Child and Adolescent Psychiatry, 24, 1091–1098.
27. Maruff, P., & Falleti, M. (2005). Cognitive function in growth hormone deficiency and growth hormone replacement. Hormone Research, 64(Suppl. 3), 100–108.
28. Mogul, H.R., Lee, P.D., Whitman, B.Y., Zipf, W.B., Frey, M., Myers, S., … & Southren, A.L. (2008). Growth hormone treatment of adults with Prader-Willi syndrome improves body mass, fractional body fat and serum triodothyronine without glucose impairment. Journal of Clinical and Endocrinology Metabolism, 93, 1238–1245.
29. Moreau, O.K., Cortet-Rudell, C., Yollin, E., Merlen, E., Daveluy, W., & Rousseaux, M. (2013). Growth hormone replacement therapy in patients with traumatic brain injury. Journal of Neurotrauma, 30, 998–1006.
30. Myers, S.E., Whitman, B.Y., Carrel, A.L., Moerchen, V., Bekx, M.T., & Allen, D.B. (2006). Two years of growth hormone therapy in young children with Prader-Willi syndrome: Physical and neurodevelopmental benefits. American Journal of Medical Genetics, 143A, 443–448.
31. Nyberg, F. (2000). Growth hormone in the brain: Characteristics of specific brain targets for the hormone and their functional significance. Frontiers in Neuroendocrinology, 21, 330–348.
32. Nyberg, F., & Hallberg, M. (2013). Growth hormone and cognitive function. Nature Reviews Endocrinology, 9, 357–365.
33. Raudenbush, S.W., & Bryk, A.S. (2002). Hierarchical linear models: Applications and data analysis methods (2nd edn). Thousand Oaks, CA: Sage.
34. Raudenbush, S.W., Bryk, A.S., & Congdon, R. (2004). HLM 6 for windows [Computer software]. Lincolnwood, IL: Scientific Software International.
35. Reus, L., Pelzer, B.J., Otten, B.J., Siemensma, E.P., van Alfen-van der Velden, J.A., Festen, D.A., … & Nijhuis-van der Sanden, M.W. (2013). Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome: A randomized controlled trial. Research in Developmental Disabilities, 34, 3092–3103.
36. Saunamäki, T., & Jehkonen, M. (2007). Review of executive functions in obstructive sleep apnea syndrome. Acta Neurologica Scandinavica, 115, 1–11.
37. Sedky, K., Bennett, D.S., & Pumariega, A. (2014). Prader-Willi syndrome and obstructive sleep apnea: Co-occurrence in the pediatric population. Journal of Clinical Sleep Medicine, 10, 403–409.
38. Siemensma, E.P., Tummers-de Lind van Wijngaarden, R.F., Festen, D.A., Troeman, Z.C., van Alfen-van der Velden, A.A., Otten, B.J., … & Hokken-Koelega, A.C. (2012). Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: A randomized controlled trial and longitudinal study. Journal of Clinical Endocrinology and Metabolism, 97, 2307–2314.
39. Sparrow, S.S., Cicchetti, D.V., & Balla, D.A. (2005). Vineland Adaptive Behavior Scales-II. Minneapolis, MN: Pearson.
40. Takeda, A., Cooper, K., Bird, A., Baxter, L., Frampton, G.K., Gospodarevskaya, E., … & Bryant, J. (2010). Recombinant human growth hormone for the treatment of growth disorders in children: A systematic review and economic evaluation. Health Technology Assessment, 14, 1–100.
41. Turkheimer, E., Haley, A., Waldron, M., D'Onofrio, B., & Gottesman, I. (2001). Socioeconomic status modifies heritability of IQ in young children. Psychological Science, 14, 623–628.
42. van Nieuwpoort, I.C., Deijen, J.B., Curfs, L.M.G., & Drent, M.L. (2011). The relationship between IGF-I concentration, cognitive function and quality of life in adults with Prader-Willi syndrome. Hormones and Behavior, 59, 444–450.
43. Wass, J.A.H., & Reddy, R. (2010). Growth hormone and memory. Journal of Endocrinology, 207, 125–126.
44. West, S.G., Duan, N., Pequegnat, W., Gaist, P., Des Jarlais, D.C., Holtgrave, D., … & Mullen, P.D. (2008). Alternatives to the randomized controlled trial. American Journal of Public Health, 98, 1359–1366.
45. Whittington, J., Holland, A., Webb, T., Butler, J., Clarke, D., & Boer, H. (2004). Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome. Journal of Intellectual Disability Research, 48, 172–187.